These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2516498)

  • 1. Multistage mastocytoma model characterized by autocrine IL-3 production.
    Moroni C; Diamantis ID; Wodnar-Filipowicz A; Nair AP
    Haematol Blood Transfus; 1989; 32():407-10. PubMed ID: 2516498
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.
    Diamantis ID; Nair AP; Hirsch HH; Moroni C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9299-302. PubMed ID: 2512578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production.
    Nair AP; Diamantis ID; Conscience JF; Kindler V; Hofer P; Moroni C
    Mol Cell Biol; 1989 Mar; 9(3):1183-90. PubMed ID: 2498644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells sensitive to v-H-ras transformation are hyperinducible for interleukin 3 expression and have lost tumor-suppressor activity.
    Nair AP; Hirsch HH; Moroni C
    Oncogene; 1992 Oct; 7(10):1963-72. PubMed ID: 1408138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.
    Aebersold DM; Banholzer R; Backenstoss V; Hirsch HH; Moroni C
    Exp Hematol; 1997 May; 25(5):395-404. PubMed ID: 9168061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukin 3 gene.
    Hirsch HH; Nair AP; Moroni C
    J Exp Med; 1993 Aug; 178(2):403-11. PubMed ID: 8340751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrangement of inverted repetitive and unique DNA sequences in genome of mouse P815 mastocytoma cells.
    Boehm TL; Drahovsky D
    Int J Biochem; 1980; 11(3-4):251-8. PubMed ID: 6771167
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA.
    Nair AP; Hahn S; Banholzer R; Hirsch HH; Moroni C
    Nature; 1994 May; 369(6477):239-42. PubMed ID: 8183344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative quiescence of normal mast cells resembles that of cold-sensitive mutant mastocytoma cells. Dominant expression of the quiescent state in heterokaryons.
    Laeng H; Harris DT; Schindler R
    Exp Cell Res; 1985 May; 158(1):170-6. PubMed ID: 3922778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation status, cytokine action and protein tyrosine phosphorylation modulate leukotriene biosynthesis in a basophil leukaemia and a mastocytoma cell line.
    Hagmann W
    Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):467-72. PubMed ID: 7513514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-promoting phorbol ester and activated Ha-ras synergistically reduce the interleukin 3 requirement in a mast cell line.
    Imber R; Fabbro D
    Cancer Res; 1991 Jan; 51(2):632-8. PubMed ID: 1985780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras oncogenes amplify lymphokine (interleukin 3, granulocyte-macrophage colony-stimulating factor) induction by calcium ionophore.
    Hahn S; Wodnar-Filipowicz A; Nair AP; Moroni C
    Oncogene; 1991 Dec; 6(12):2327-32. PubMed ID: 1722572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyclonal and monoclonal IgGs from MRL/Mp-lpr/lpr mice induce an interleukin-3-dependent cell line to produce interleukin-3 through an Fc gamma-receptor-mediated mechanism.
    Sakihama T; Akasu F; Iwamoto M; Shirakura-Shibata Y; Okada Y; Nakajima Y; Tasaka K
    Cell Immunol; 1990 Jan; 125(1):160-70. PubMed ID: 2136717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta production by dog mastocytoma cells. Storage and release from mast cell granules.
    Pennington D; Thomas P; Lopez A; Gold W
    Chest; 1991 Mar; 99(3 Suppl):66S. PubMed ID: 1900044
    [No Abstract]   [Full Text] [Related]  

  • 15. Secretory heparin in murine mastocytoma cell lines.
    Esko JD; Montgomery RI; Lindahl U
    Biochem Soc Trans; 1990 Oct; 18(5):807-9. PubMed ID: 2128061
    [No Abstract]   [Full Text] [Related]  

  • 16. Mast cell sarcoma in an infant: a case report and review of the literature.
    Bautista-Quach MA; Booth CL; Kheradpour A; Zuppan CW; Rowsell EH; Weiss L; Wang J
    J Pediatr Hematol Oncol; 2013 May; 35(4):315-20. PubMed ID: 23211696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic hypomethylation of inverted repeats in transcribed DNA regions of mouse P815 mastocytoma cells.
    Boehm TR; Drahovsky D
    Int J Biochem; 1981; 13(2):153-8. PubMed ID: 6781949
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasminogen activator production from murine mastocytoma cells. Dissociation of plasminogen activator and histamine production by sodium butyrate.
    Katayama I; Hashimoto K; Nishioka K
    Int Arch Allergy Appl Immunol; 1986; 81(1):42-5. PubMed ID: 2427454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response.
    Nagarajan S; Selvaraj P
    Cancer Res; 2002 May; 62(10):2869-74. PubMed ID: 12019166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfection of IL-3 gene to a factor-dependent murine myeloid cell line (FDC-P2).
    Suda T; Ohno M; Suda J; Saito M; Miura Y; Kitamura Y
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1498-504. PubMed ID: 3266817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.